Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.11-68.1133.8294.6045.00

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is 2.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.11
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.11
Positive
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹103.7 Cr -0.3% -4.5% -52.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-0.3%

-4.5%

-52.3%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses